/

BFRG

Bullfrog AI Holdings, Inc.Open

0.5701−0.01 −2.35%USD

NasdaqCM · as of Oct 13, 15:42 ET · 15m delay

Open

0.5880

Prev close

0.5838

Day range

0.54780.5880

52-week range

0.42501.96

Volume

298.05K0.06×

Mkt cap

10.57M

P/E ttm

—

Fwd P/E

-3.35

EPS ttm

-0.4600

Div yield

0.00%

Earnings

—

From 52w high

−70.91%

Price Chart

Yahoo Finance · delayed

BFRGOct 13, 2026O 0.5880H 0.5880L 0.5478C 0.5701−0.0139 (−2.38%)Vol 298.05K

SMA 500.5753
SMA 2000.6748

1Y change −56.81% since Oct 10, 2025 close540 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

BFRG Bullfrog AI Holdings, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −17.26%
1 month: +19.77%
3 months: −17.73%
6 months: −43.55%
Year to date: −35.44%
1 year: −61.74%

Valuation & ownership

Market cap: 10.57M
Enterprise value: 4.00M
P/E (ttm): —
Forward P/E: -3.35
PEG ratio: —
Price / book: 1.51
Price / sales (ttm): 35.38
EV / EBITDA: -0.66
EPS (ttm): -0.4600
EPS (forward): -0.1700
Beta (5y monthly): -2.74
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 18.54M
Float: 15.97M
Short % of float: 4.58%
Short ratio (days): 0.06
Held by insiders: 13.54%
Held by institutions: 6.36%
Avg volume (3m): 5.36M
50-day average: 0.5754
200-day average: 0.6770
52-week change: −61.74%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 46.7
vs 50-day SMA: −0.90%
vs 200-day SMA: −15.52%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 16.70%
Realised vol (20d, ann.): 223.0%
From 52-week high: −70.91%
From 52-week low: +34.14%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): 298.80K
Revenue growth (yoy): +547.60%
Earnings growth (yoy): —
Gross margin: 40.92%
Operating margin: -658.85%
Profit margin: 0.00%

DES

About Bullfrog AI Holdings, Inc.

Yahoo Finance profile

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.

Sector: Healthcare
Industry: Health Information Services
Employees: 9
Headquarters: Gaithersburg, MD, United States
Website: bullfrogai.com
Officers: Mr. Vininder Singh Founder, Chairman & CEO

SEAS

Seasonality · BFRG

2023–2026 · monthly returns

Strongest month Jan +33.47%Weakest month Jun −26.14%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-30.9	-4.9	189.7	-58.3	8.1	-6.3	-21.8	-3.6	12.3	-5.1			−35.4%
2025	17.3	-10.9	-21.1	7.3	-3.4	-11.7	-9.3	-11.7	15.7	-8.6	-21.9	-11.7	−55.8%
2024	49.7	0.8	-34.8	-2.2	-8.0	-40.1	70.5	-12.5	11.2	-20.6	-5.7	-7.0	−38.7%
2023			14.9	31.9	8.5	-26.6	38.5	-33.5	-0.6	-14.1	2.1	14.0	+10.5%

INSD

Insider Activity · BFRG

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Sep 21, 2026	Blacher JoshuaChief Financial Officer	Purchase at price 0.53 per share.	50K	$26.43K
Sep 21, 2026	Singh VininderChief Executive Officer	Purchase at price 0.49 per share.	75K	$36.98K
Aug 21, 2025	Hanson Jason DavidDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
Aug 21, 2025	Enright WilliamDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
Aug 21, 2025	Elsey Raymond DonaldDirector	Stock Award(Grant) at price 0.00 per share.	8.5K	—
Aug 21, 2025	Blacher JoshuaChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	15K	—
Aug 21, 2025	Singh VininderChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	75K	—
Jul 6, 2025	Singh VininderChief Executive Officer	Sale at price 1.50 per share.	29K	$43.63K
Jul 2, 2025	Singh VininderChief Executive Officer	Sale at price 1.53 - 1.61 per share.	21K	$32.91K
Apr 3, 2025	Singh VininderChief Executive Officer	Sale at price 1.30 per share.	5.9K	$7.69K
Apr 2, 2025	Singh VininderChief Executive Officer	Sale at price 1.44 - 1.64 per share.	44.1K	$66.41K

BFRG

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

BFRG

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Bullfrog AI Holdings, Inc.

Seasonality · BFRG

Insider Activity · BFRG

Congress Trades · BFRG

Investors Holding BFRG

Investors Holding BFRG

Congress Trades · BFRG

Insider Activity · BFRG

Seasonality · BFRG

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Bullfrog AI Holdings, Inc.

Earnings & Dividends

News